StockNews.AI
VIGL
StockNews.AI
89 days

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, TXNM, SVT, PTIX on Behalf of Shareholders

1. Vigil Neuroscience is under investigation for possible shareholder rights violations. 2. Vigil's sale to Sanofi promises $8.00 per share plus conditional $2.00. 3. Halper Sadeh LLC seeks potential legal remedies for Vigil shareholders. 4. Shareholders can discuss their legal options free of cost. 5. The firm has a history of recovering funds for defrauded investors.

5m saved
Insight
Article

FAQ

Why Neutral?

While the sale offers cash and potential future payments, the investigation raises concerns. Similar cases saw stock stability despite initial legal inquiries.

How important is it?

The ongoing investigation could lead to alterations in shareholder rights and financial outcomes, making it crucial for investors.

Why Short Term?

The investigation could impact investor sentiment and stock performance in the immediate future. However, pending closure of the deal might stabilize prices.

Related Companies

NEW YORK, May 22, 2025 /PRNewswire/

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Vigil Neuroscience, Inc. (NASDAQ: VIGL)

's sale to Sanofi. Under the terms of the proposed transaction, Vigil shareholders will receive $8.00 per share in cash and a non-tradeable contingent value right entitling shareholders to potentially receive an additional $2.00 per share in cash payable following the first commercial sale of VG-3927 if achieved within a specific period. If you are a Vigil shareholder, click here to learn more about your legal rights and options.

TXNM Energy, Inc. (NYSE: TXNM)

's sale to Blackstone for $61.25 per share in cash. If you are a TXNM shareholder, click here to learn more about your legal rights and options.

Servotronics, Inc. (NYSE: SVT)

's sale to TransDigm Group Incorporated for $38.50 per share in cash. If you are a Servotronics shareholder, click here to learn more about your rights and options.

Protagenic Therapeutics, Inc. (NASDAQ: PTIX)

's merger with Phytanix Bio Inc. Upon completion of the proposed transaction, Protagenic shareholders are expected to own approximately 35% of the combined company. If you are a Protagenic shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Related News